HealthCareMagic is now Ask A Doctor - 24x7 | https://www.askadoctor24x7.com

question-icon

Provide Advice Regarding Stem Cells And Gene Therapy For One With Genetic Mutation Of Adipocyte Triglyceride Lipase Deficiency And Has Cardiac Involvement

default
Posted on Wed, 9 Feb 2022
Question: Have a 50 year old male patient with diagnosed genetic mutation of adipocyte triglyceride lipase deficiency and has cardiac involvement and is seeking help of any type. Asked me about stem cells and gene therapy. Thoughts?
doctor
Answered by Dr. Mirjeta Guni (7 hours later)
Brief Answer:
About glybera;

Detailed Answer:

Hello,

Yes, you may suggest to your patient gene therapy.
The gene-therapy product Glybera (alipogene tiparvovec), approved by the European Medicines Agency in 2012 for patient with lipoproteine lipase deficiency who have a condition that can cause life threatening (pancreatitis, myocardial infarction ) diseases can be effective in reducing 40% fasting tryglicerides reducing the risk for severe complications.

In your living area, I do not know if it is available but he should get interested at pharmaceutical companies.

Best wishes,
Dr.Mirjeta
Note: For more information on hormonal imbalance symptoms or unmanaged diabetes with other comorbid conditions, get back to us & Consult with an Endocrinologist. Click here to book an appointment.

Above answer was peer-reviewed by : Dr. Nagamani Ng
doctor
Answered by
Dr.
Dr. Mirjeta Guni

Endocrinologist

Practicing since :2006

Answered : 2414 Questions

premium_optimized

The User accepted the expert's answer

Share on

Get personalised answers from verified doctor in minutes across 80+ specialties

159 Doctors Online

By proceeding, I accept the Terms and Conditions

HCM Blog Instant Access to Doctors
HCM Blog Questions Answered
HCM Blog Satisfaction
Provide Advice Regarding Stem Cells And Gene Therapy For One With Genetic Mutation Of Adipocyte Triglyceride Lipase Deficiency And Has Cardiac Involvement

Brief Answer: About glybera; Detailed Answer: Hello, Yes, you may suggest to your patient gene therapy. The gene-therapy product Glybera (alipogene tiparvovec), approved by the European Medicines Agency in 2012 for patient with lipoproteine lipase deficiency who have a condition that can cause life threatening (pancreatitis, myocardial infarction ) diseases can be effective in reducing 40% fasting tryglicerides reducing the risk for severe complications. In your living area, I do not know if it is available but he should get interested at pharmaceutical companies. Best wishes, Dr.Mirjeta